Delivery Order SPE2DB22D3010-SPE2DB26FP0RA
Award Date 10/15/25
Potential Completion Date 11/5/25
Potential Value $3.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,027.70 for INGREZZA 80 mg capsules (30-count) on September 15, 2025, with completion targeted for October 6, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. INGREZZA is a prescription medication used in the treatment of involuntary movement disorders,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of INGREZZA 40 mg capsules (30-count units) valued at $3,676.12. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by October 14, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. INGREZZA is a prescription medication used to treat tardive dyskinesia, a...
- The Defense Logistics Agency awarded a delivery order valued at $14.7K to AmerisourceBergen Drug Corp for INGREZZA 40 mg capsules (30-count units) on September 17, 2025, with an ultimate completion date of October 8, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be performed at the contractor's location in Conshohocken, Pennsylvania. INGREZZA is a prescription medication used in the treatment of tardive dyskinesia, a neurological movement disorder,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of INGREZZA 40 mg capsules (30-count units) under a firm fixed-price contract valued at $11,028.36. This non-competitive delivery order, issued on September 19, 2025, with completion targeted for October 10, 2025, will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. INGREZZA is a prescription medication used to treat involuntary movement disorders associated with...
- The Defense Logistics Agency awarded a $11,028.36 delivery order to AmerisourceBergen Drug Corp for INGREZZA 40 MG capsules (30-count units) on August 25, 2025, with completion expected by September 16, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitive award to the pharmaceutical distributor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $4,049.61 delivery order to AmerisourceBergen Drug Corp for INGREZZA 60 mg capsules (30-count units) on June 2, 2025, with a completion date of June 24, 2025. This non-set-aside contract utilizes firm fixed pricing and is classified as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for INGREZZA 80 mg capsules (30-count units) with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply needs. The contractor will perform under this order at its corporate office location in Conshohocken, Pennsylvania. This delivery order operates under...
- The Defense Logistics Agency awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for the supply of INGREZZA 80 mg capsules (30-count) on August 25, 2025, with completion targeted for September 16, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. INGREZZA is a prescription medication used in the treatment of tardive dyskinesia, a neurological...
- The Defense Logistics Agency awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for INGREZZA 80 mg capsules (30-count units) on June 2, 2025, with an ultimate completion date of June 24, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. INGREZZA is a pharmaceutical treatment indicated for tardive dyskinesia, a neurological movement disorder,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of INGREZZA 40 mg capsules (30-count units) with a contract ceiling value of $11,028.36. This is a firm fixed-price delivery order with no set-aside designation, executed under competitive procedures. The order is scheduled for ultimate completion by September 29, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This...